STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
Signal transducer and activator of transcription 3 (STAT3) is a potent regulator of gliomagenesis through its induction of angiogenesis, host immunosuppression, and tumor invasion. Gain of function mutations result in constitutive activation of STAT3 in glioma cells, making STAT3 an attractive targe...
Main Authors: | Jennifer E. Kim, Mira Patel, Jacob Ruzevick, Christopher M. Jackson, Michael Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/6/1/376 |
Similar Items
-
The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
by: Alexander Ou, et al.
Published: (2021-01-01) -
The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy
by: Mira A. Patel, et al.
Published: (2014-09-01) -
The role of p-Stat3 Y705 immunohistochemistry in glioblastoma prognosis
by: Sergiu Susman, et al.
Published: (2019-11-01) -
SH2B3, Transcribed by STAT1, Promotes Glioblastoma Progression Through Transducing IL-6/gp130 Signaling to Activate STAT3 Signaling
by: Shan Cai, et al.
Published: (2021-04-01) -
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
by: Carla Lucia Esposito, et al.
Published: (2018-03-01)